LIANG Huanhuan, CHANG Keting, XIAO Sa, LI Huizhen, XING Yurong. Self-management level and its influencing factors among patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 140-143. DOI: 10.7619/jcmp.20241729
Citation: LIANG Huanhuan, CHANG Keting, XIAO Sa, LI Huizhen, XING Yurong. Self-management level and its influencing factors among patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 140-143. DOI: 10.7619/jcmp.20241729

Self-management level and its influencing factors among patients with nonalcoholic fatty liver disease

More Information
  • Received Date: April 25, 2024
  • Revised Date: July 12, 2024
  • Objective 

    To analyze the level of self-management and its influencing factors among patients with nonalcoholic fatty liver disease (NAFLD).

    Methods 

    A total of 129 patients with NAFLD were recruited using convenience sampling method as study participants. A questionnaire survey was conducted among these patients using general information questionnaire, self-management scale, and health behavior competence scale. Multivariate linear regression analysis was employed to identify the factors influencing the level of self-management among NAFLD patients.

    Results 

    The overall score of the self-management scale among NAFLD patients was (77.60±21.68). A positive correlation was observed between various dimensions of health behavior score and self-management score (P < 0.05). Monthly income, exercise frequency, dietary habits and mental health status were identified as significant influencing factors of self-management level among NAFLD patients (P < 0.05).

    Conclusion 

    The self-management level of NAFLD patients is moderate and is influenced by their monthly income, exercise habits, dietary habits and mental health status. Healthcare professionals should develop targeted intervention programs addressing these factors to enhance patients' self-management capabilities.

  • [1]
    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018, 26(3): 195-203. doi: 10.3760/cma.j.issn.1007-3418.2018.03.008
    [2]
    ESLAM M, EL-SERAG H B, FRANCQUE S, et al. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(10): 638-651. doi: 10.1038/s41575-022-00635-5
    [3]
    CASTERA L, FRIEDRICH-RUST M, LOOMBA R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2019, 156(5): 1264-1281, e4. doi: 10.1053/j.gastro.2018.12.036
    [4]
    TAHERI E, BOSTICK R M, HATAMI B, et al. Dietary and lifestyle inflammation scores are inversely associated with metabolic-associated fatty liver disease among Iranian adults: a nested case-control study[J]. J Nutr, 2022, 152(2): 559-567. doi: 10.1093/jn/nxab391
    [5]
    ZHANG W, CHAO S, CHEN S, et al. Awareness and knowledge of nonalcoholic fatty liver disease among office employees in Beijing, China[J]. Dig Dis Sci, 2019, 64(3): 708-717. doi: 10.1007/s10620-018-5389-5
    [6]
    RIEGEL B, MCKINLEY S, MOSER D K, et al. Psychometric evaluation of the Acute Coronary Syndrome (ACS) Response Index[J]. Res Nurs Health, 2007, 30(6): 584-594. doi: 10.1002/nur.20213
    [7]
    李文利, 许妍, 赵卫红. 自我管理教育模式对非酒精性脂肪性肝病患者生活质量的影响[J]. 护理与康复, 2009, 8(4): 276-277.
    [8]
    郜慧. KH健康教育对非酒精性脂肪肝病患者自我管理的影响[J]. 吉林医药学院学报, 2022, 43(3): 177-179.
    [9]
    杨磊. 基于潜在类别分析模型的非酒精性脂肪性肝病患者自我管理现状研究[D]. 乌鲁木齐: 新疆医科大学, 2022.
    [10]
    徐倩. 非酒精性脂肪性肝病患者自我管理量表的初步编制及信效度检验[D]. 武汉: 湖北中医药大学, 2018.
    [11]
    BECKER H, STUIFBERGEN A, OH H S, et al. Self-rated abilities for health practices: A health self-efficacy measure[J]. Health Values: The Journal of Health Behavior, Education & Promotion, 1993, 17(5): 42-50.
    [12]
    罗德宝. 多学科协作联合延续性护理对非酒精性脂肪肝患者血脂及自我管理行为的影响[J]. 中外医药研究, 2023, 2(4): 92-94.
    [13]
    杨磊, 周青, 朱凯, 等. 非酒精性脂肪性肝病患者健康促进生活方式与自我管理行为的关系研究[J]. 护理管理杂志, 2023, 23(4): 271-275.
    [14]
    梁海莉, 王晖, 汪停, 等. 非酒精性脂肪性肝病患者自我管理现状及影响因素分析[J]. 中国医药导报, 2020, 17(20): 46-49, 53.
    [15]
    周颖, 方林花, 林敏, 等. 非酒精性脂肪性肝病患者自我健康管理水平及影响因素分析[J]. 中国公共卫生管理, 2021, 37(4): 469-472.
    [16]
    梁乾飞, 王亚东, 赵彩彦. 河北省居民非酒精性脂肪性肝病的认知调查与分析[J]. 中华肝脏病杂志, 2017, 25(10): 760-765.
    [17]
    CLEVELAND E R, NING H Y, VOS M B, et al. Low awareness of nonalcoholic fatty liver disease in a population-based cohort sample: the CARDIA study[J]. J Gen Intern Med, 2019, 34(12): 2772-2778. doi: 10.1007/s11606-019-05340-9
    [18]
    HALLSWORTH K, DOMBROWSKI S U, MCPHERSON S, et al. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study[J]. Transl Behav Med, 2020, 10(4): 1016-1030. doi: 10.1093/tbm/ibz080
    [19]
    殷宪华. 2型糖尿病患者自我管理行为现状及影响因素分析[J]. 当代护士, 2023, 30(4): 47-50.
    [20]
    赵培培, 蒋玲, 李科. 高血压患者自我健康管理现状及影响因素研究[J]. 华南预防医学, 2023, 49(1): 10-13.
    [21]
    林秀丽, 鲍少蕊, 黄海萍, 等. 数据挖掘技术在构建非酒精性脂肪肝患者自我管理关联规则中的应用[J]. 温州医科大学学报, 2023, 53(9): 749-753.
    [22]
    孔婷婷, 张伟, 谷云鹏, 等. 非酒精性脂肪性肝病患者自我管理需求质性研究的Meta整合[J]. 中华现代护理杂志, 2023, 29(30): 4121-4127.
  • Related Articles

    [1]DU Juan, WU Hua, DING Ning, LIU Jia. Effect of recombinant human brain natriuretic peptide combined with furosemide in improvement of cardiac function and blood gas indicators in patients with acute myocardial infarction complicated with heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 80-83, 89. DOI: 10.7619/jcmp.20241336
    [2]ZHU Qi, JI Meili, ZHUANG Shihong. Correlations between soluble growth stimulation expressed gene 2 protein, myoglobin, interleukin-6 levels and cardiac function in elderly patients with diastolic heart failure complicated with sarcopenia[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 57-61. DOI: 10.7619/jcmp.20234138
    [3]SU Jianpei, WANG Yongli, WANG Zhimin, WU Qi, GU Jun, LI Jin, LIANG Bijuan. Effects of dapagliflozin on inflammatory cytokines and cardiac function in elderly patients with preserved ejection fraction heart failure complicated with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 85-89,95. DOI: 10.7619/jcmp.20233206
    [4]XING Xiaona, LIU Lijun, HE Yuanjun. Protective effects of nicorandil on cardiac function in rats with ischemic heart failure and its mechanism[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 94-98. DOI: 10.7619/jcmp.20201334
    [5]SUN Wei, WANG Caiyan. Effect of amiodarone in adjuvant treatment of rapid atrial fibrillation combined with heart failure and its effect on heart function[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 63-65. DOI: 10.7619/jcmp.202012018
    [6]LING Jia, ZHUANG Xiaohua, KAN Lihong, CAI Zhenrong, ZHU Zhongsheng. Correlation between levels of serum procollagen Ⅲ N-terminal peptide and galectin 3 and cardiac function in elderly patients with intractable heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 14-17. DOI: 10.7619/jcmp.202005004
    [7]LIU Yuxia. Effect of clinical nursing intervention on cardiac functional status and life quality of patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2017, (6): 8-10. DOI: 10.7619/jcmp.201706003
    [8]Influence of lyophilized recombinant human brain natriuretic peptide on NT-proBNP and cardiac function of AMI patients complicated with HF[J]. Journal of Clinical Medicine in Practice, 2015, (23): 1-3,11. DOI: 10.7619/jcmp.201523001
    [9]LIU Xubang, WEI Juanling. Influence of positive airway pressure ventilation on blood gas indexes and cardiac function indexes of patients with acute heart failure[J]. Journal of Clinical Medicine in Practice, 2015, (1): 95-97. DOI: 10.7619/jcmp.201501029
    [10]CHEN Dongyun, HUANG Dajun. Influence and safety of milinong and nitrate yamanashi ester on cardiac function of patients with congestive heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (13): 94-96. DOI: 10.7619/jcmp.201413031
  • Cited by

    Periodical cited type(4)

    1. 薛晓丹,周艳菲,阎慧娟. 保留子宫的经阴道骶棘韧带悬吊术治疗中重度盆腔器官脱垂患者的效果研究. 实用临床医药杂志. 2025(04): 87-91 . 本站查看
    2. 林伟雄,卢燕. 骶韧带阻滞的研究进展. 中外医学研究. 2024(25): 176-180 .
    3. 张红英,申丽辉. 传统单侧骶棘韧带固定术治疗盆腔脱垂的疗效. 中国城乡企业卫生. 2024(12): 161-163 .
    4. 郭娟,刘艳,邵琰玉,王一娜,许洁. 经阴道骶棘韧带固定术联合传统阴式手术治疗中重度盆腔器官脱垂的临床疗效. 中国医师杂志. 2024(11): 1691-1694 .

    Other cited types(0)

Catalog

    Article views (65) PDF downloads (10) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return